Know Cancer

or
forgot password

Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome


N/A
2 Years
60 Years
Open (Enrolling)
Both
Advanced MDS Without Identical Sibling Donor

Thank you

Trial Information

Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome


Inclusion Criteria:



- Patients with MDS (1)intermediate-2 or high risk (2)low or intermediate-1 risk with
drug resistance or disease progression

- without identical sibling donor

Exclusion Criteria:

- Contraindication to HSCT

- Pregnancy

- Mental illness

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

survival rate

Outcome Description:

number of participants with survival at one year

Outcome Time Frame:

participants will be followed for an expected average of one year

Safety Issue:

No

Principal Investigator

xiaojun huang, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Peking University People's Hospital

Authority:

China: Ministry of Health

Study ID:

PUPH IRB [2013] (04)

NCT ID:

NCT01793675

Start Date:

April 2003

Completion Date:

December 2014

Related Keywords:

  • Advanced MDS Without Identical Sibling Donor
  • Myelodysplastic Syndromes
  • Preleukemia

Name

Location